---
schema_version: "secwatch.filing_event.v1"
accession: "0001104659-24-039006"
form_type: "8-K"
ticker: "NVAX"
cik: "0001000694"
company_name: "NOVAVAX INC"
filed_at: "2024-03-26T23:59:59+00:00"
generated_at: "2026-06-04T07:31:53.280239+00:00"
event_type: "litigation"
sentiment: "positive"
materiality_score: 0.8
calibrated_materiality_score: 0.8
confidence: "high"
source: SEC EDGAR
---

# Novavax settles manufacturing dispute with Fujifilm for $42M, releases claims

## Summary
- Paid $42M on March 25, 2024 to Fujifilm, resolving $68.6M disputed installments under prior cancellation agreement.
- Mutual release of all claims; Fujifilm agreed to dismiss pending arbitration from October 2023.
- Original liability under Prior SAR was up to $185 million; settlement removes uncertainty and potential larger payout.

## SEC filing metadata
- accession: 0001104659-24-039006
- form_type: 8-K
- ticker: NVAX
- cik: 0001000694
- company_name: NOVAVAX INC
- filed_at: 2024-03-26T23:59:59+00:00
- event_type: litigation
- sentiment: positive
- materiality_score: 0.8
- calibrated_materiality_score: 0.8
- confidence: high
- sec_items: 1.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1000694/000110465924039006/0001104659-24-039006-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1000694/000110465924039006/tm249881d1_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001104659-24-039006
- JSON: https://secwatch.observer/filing/0001104659-24-039006.json
- Plain text: https://secwatch.observer/filing/0001104659-24-039006.txt

## Key facts
- Material Agreements
  NOVAVAX INC entered into Confidential Settlement Agreement and Release with FUJIFILM Diosynth Biotechnologies UK Limited, FUJIFILM Diosynth Biotechnologies Texas, LLC, and FUJIFILM Diosynth Biotechnologies USA, Inc. (effective 2024-03-21).
  - Action: entry
  - Agreement: settlement
  - Counterparty: FUJIFILM Diosynth Biotechnologies UK Limited, FUJIFILM Diosynth Biotechnologies Texas, LLC, and FUJIFILM Diosynth Biotechnologies USA, Inc.
  - Effective: 2024-03-21
  source text: On March 21, 2024, Novavax, Inc. (the “Company”), FUJIFILM Diosynth Biotechnologies UK Limited (“FDBK”), FUJIFILM Diosynth Biotechnologies Texas, LLC (“FDBT”) and FUJIFILM Diosynth Biotechnologies USA, Inc. (“FDBU” and together with FDBK and FDBT, “Fujifilm”) entered into a Confidential Settlement Agreement and Release (the “Settlement Agreement”) to resolve disputes
  evidence_url: https://www.sec.gov/Archives/edgar/data/1000694/000110465924039006/0001104659-24-039006-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.